Medicine Supply Notification: Oxybutynin (Kentera®) 3.9mg/24hour transdermal patches.
Thursday 17th March 2022
Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Oxybutynin (Kentera®) 3.9mg/24hour transdermal patches.
MSN/2022/027
Tier 2 – medium impact
Date of issue: 16/03/2022
- Oxybutynin (Kentera®) 3.9mg/24hour transdermal patches are out of stock until w/c 30th May 2022.
- Oxybutynin (Lyrinel XL®) 5mg and 10mg modified-release tablets are available but cannot support an
increase in demand during this time. - Alternative medicines for urinary disorders remain available and can support an uplift in demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool. To access the Tool you will be required to register with the SPS website.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
Thursday 17th March 2022
